SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-24-002635
Filing Date
2024-01-31
Accepted
2024-01-31 06:51:16
Documents
223
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 20-F nvo-20231231.htm   iXBRL 20-F 1352034
2 EX-2.1 exhibit21descriptionofther.htm EX-2.1 111559
3 EX-2.2 exhibit22descriptionofther.htm EX-2.2 24566
4 EX-12.1 exhibit121certificationlfj.htm EX-12.1 10759
5 EX-12.2 exhibit122certificationkmk.htm EX-12.2 10485
6 EX-13.1 exhibit131906certification.htm EX-13.1 7105
7 EX-15.1 nvo-20231231_d2.htm   iXBRL EX-15.1 3657927
8 EX-15.2 exhibit152consentofindepen.htm EX-15.2 2524
9 EX-97 exhibit97compensationrecov.htm EX-97 30156
15 nvo-20231231_g1.jpg GRAPHIC 389216
16 nvo-20231231_g10.jpg GRAPHIC 5108
17 nvo-20231231_g100.jpg GRAPHIC 40770
18 nvo-20231231_g101.jpg GRAPHIC 40944
19 nvo-20231231_g102.jpg GRAPHIC 38651
20 nvo-20231231_g103.jpg GRAPHIC 35739
21 nvo-20231231_g104.jpg GRAPHIC 15897
22 nvo-20231231_g105.jpg GRAPHIC 16836
23 nvo-20231231_g106.jpg GRAPHIC 37739
24 nvo-20231231_g107.jpg GRAPHIC 42108
25 nvo-20231231_g108.jpg GRAPHIC 15656
26 nvo-20231231_g109.jpg GRAPHIC 553638
27 nvo-20231231_g11.jpg GRAPHIC 5111
28 nvo-20231231_g110.jpg GRAPHIC 1693791
29 nvo-20231231_g111.jpg GRAPHIC 4351
30 nvo-20231231_g112.jpg GRAPHIC 4176
31 nvo-20231231_g113.jpg GRAPHIC 4532
32 nvo-20231231_g114.jpg GRAPHIC 5473
33 nvo-20231231_g12.jpg GRAPHIC 4896
34 nvo-20231231_g13.jpg GRAPHIC 5024
35 nvo-20231231_g14.jpg GRAPHIC 297199
36 nvo-20231231_g15.jpg GRAPHIC 46538
37 nvo-20231231_g16.jpg GRAPHIC 14681
38 nvo-20231231_g17.jpg GRAPHIC 115706
39 nvo-20231231_g18.jpg GRAPHIC 15105
40 nvo-20231231_g19.jpg GRAPHIC 128569
41 nvo-20231231_g2.jpg GRAPHIC 4074
42 nvo-20231231_g20.jpg GRAPHIC 138472
43 nvo-20231231_g21.jpg GRAPHIC 10405
44 nvo-20231231_g22.jpg GRAPHIC 159408
45 nvo-20231231_g23.jpg GRAPHIC 34799
46 nvo-20231231_g24.jpg GRAPHIC 208667
47 nvo-20231231_g25.jpg GRAPHIC 155393
48 nvo-20231231_g26.jpg GRAPHIC 86497
49 nvo-20231231_g27.jpg GRAPHIC 25781
50 nvo-20231231_g28.jpg GRAPHIC 14886
51 nvo-20231231_g29.jpg GRAPHIC 127845
52 nvo-20231231_g3.jpg GRAPHIC 137953
53 nvo-20231231_g30.jpg GRAPHIC 149793
54 nvo-20231231_g31.jpg GRAPHIC 219982
55 nvo-20231231_g32.jpg GRAPHIC 38453
56 nvo-20231231_g33.jpg GRAPHIC 5904
57 nvo-20231231_g34.jpg GRAPHIC 8668
58 nvo-20231231_g35.jpg GRAPHIC 91103
59 nvo-20231231_g36.jpg GRAPHIC 148582
60 nvo-20231231_g37.jpg GRAPHIC 5611
61 nvo-20231231_g38.jpg GRAPHIC 13740
62 nvo-20231231_g39.jpg GRAPHIC 6575
63 nvo-20231231_g4.jpg GRAPHIC 294147
64 nvo-20231231_g40.jpg GRAPHIC 116272
65 nvo-20231231_g41.jpg GRAPHIC 4709
66 nvo-20231231_g42.jpg GRAPHIC 4639
67 nvo-20231231_g43.jpg GRAPHIC 4726
68 nvo-20231231_g44.jpg GRAPHIC 4835
69 nvo-20231231_g45.jpg GRAPHIC 4705
70 nvo-20231231_g46.jpg GRAPHIC 12339
71 nvo-20231231_g47.jpg GRAPHIC 4554
72 nvo-20231231_g48.jpg GRAPHIC 4733
73 nvo-20231231_g49.jpg GRAPHIC 4624
74 nvo-20231231_g5.jpg GRAPHIC 216591
75 nvo-20231231_g50.jpg GRAPHIC 4496
76 nvo-20231231_g51.jpg GRAPHIC 4531
77 nvo-20231231_g52.jpg GRAPHIC 4725
78 nvo-20231231_g53.jpg GRAPHIC 4557
79 nvo-20231231_g54.jpg GRAPHIC 4505
80 nvo-20231231_g55.jpg GRAPHIC 4734
81 nvo-20231231_g56.jpg GRAPHIC 4535
82 nvo-20231231_g57.jpg GRAPHIC 4637
83 nvo-20231231_g58.jpg GRAPHIC 4679
84 nvo-20231231_g59.jpg GRAPHIC 4569
85 nvo-20231231_g6.jpg GRAPHIC 24085
86 nvo-20231231_g60.jpg GRAPHIC 47786
87 nvo-20231231_g61.jpg GRAPHIC 104782
88 nvo-20231231_g62.jpg GRAPHIC 97899
89 nvo-20231231_g63.jpg GRAPHIC 7140
90 nvo-20231231_g64.jpg GRAPHIC 6882
91 nvo-20231231_g65.jpg GRAPHIC 39880
92 nvo-20231231_g66.jpg GRAPHIC 34614
93 nvo-20231231_g67.jpg GRAPHIC 57631
94 nvo-20231231_g68.jpg GRAPHIC 41676
95 nvo-20231231_g69.jpg GRAPHIC 54769
96 nvo-20231231_g7.jpg GRAPHIC 29675
97 nvo-20231231_g70.jpg GRAPHIC 63081
98 nvo-20231231_g71.jpg GRAPHIC 55580
99 nvo-20231231_g72.jpg GRAPHIC 87068
100 nvo-20231231_g73.jpg GRAPHIC 27522
101 nvo-20231231_g74.jpg GRAPHIC 180885
102 nvo-20231231_g75.jpg GRAPHIC 204336
103 nvo-20231231_g76.jpg GRAPHIC 44157
104 nvo-20231231_g77.jpg GRAPHIC 4427
105 nvo-20231231_g78.jpg GRAPHIC 4457
106 nvo-20231231_g79.jpg GRAPHIC 4454
107 nvo-20231231_g8.jpg GRAPHIC 125817
108 nvo-20231231_g80.jpg GRAPHIC 4446
109 nvo-20231231_g81.jpg GRAPHIC 4451
110 nvo-20231231_g82.jpg GRAPHIC 12336
111 nvo-20231231_g83.jpg GRAPHIC 4453
112 nvo-20231231_g84.jpg GRAPHIC 432967
113 nvo-20231231_g85.jpg GRAPHIC 62616
114 nvo-20231231_g86.jpg GRAPHIC 53797
115 nvo-20231231_g87.jpg GRAPHIC 61266
116 nvo-20231231_g88.jpg GRAPHIC 62091
117 nvo-20231231_g89.jpg GRAPHIC 57537
118 nvo-20231231_g9.jpg GRAPHIC 281799
119 nvo-20231231_g90.jpg GRAPHIC 53737
120 nvo-20231231_g91.jpg GRAPHIC 71721
121 nvo-20231231_g92.jpg GRAPHIC 65973
122 nvo-20231231_g93.jpg GRAPHIC 59252
123 nvo-20231231_g94.jpg GRAPHIC 51917
124 nvo-20231231_g95.jpg GRAPHIC 54598
125 nvo-20231231_g96.jpg GRAPHIC 54830
126 nvo-20231231_g97.jpg GRAPHIC 117530
127 nvo-20231231_g98.jpg GRAPHIC 37431
128 nvo-20231231_g99.jpg GRAPHIC 37379
  Complete submission text file 0001628280-24-002635.txt   43630143

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvo-20231231.xsd EX-101.SCH 158458
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nvo-20231231_cal.xml EX-101.CAL 148940
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nvo-20231231_def.xml EX-101.DEF 723844
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvo-20231231_lab.xml EX-101.LAB 1417988
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvo-20231231_pre.xml EX-101.PRE 963843
225 EXTRACTED XBRL INSTANCE DOCUMENT nvo-20231231_htm.xml XML 3986678
Mailing Address NOVO ALLE DK 2880 BAGSVAERD DENMARK G7 00000
Business Address NOVO ALLE DK 2880 BAGSVAERD DENMARK G7 00000 4544448888
NOVO NORDISK A S (Filer) CIK: 0000353278 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 333-82318 | Film No.: 24580596
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)